Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production.
RIG-I (retinoic acid-inducible gene I) and TRIM25 (tripartite motif protein 25) have emerged as key regulatory factors to induce interferon (IFN)-mediated innate immune responses to limit viral replication. Upon recognition of viral RNA, TRIM25 E3 ligase binds the first caspase recruitment domain (CARD) of RIG-I and subsequently induces lysine 172 ubiquitination of the second CARD of RIG-I, which is essential for the interaction with downstream MAVS/IPS-1/CARDIF/VISA and, thereby, IFN-beta mRNA production. Although ubiquitination has emerged as a major factor involved in RIG-I activation, the potential contribution of other post-translational modifications, such as phosphorylation, to the regulation of RIG-I activity has not been addressed. Here, we report the identification of serine 8 phosphorylation at the first CARD of RIG-I as a negative regulatory mechanism of RIG-I-mediated IFN-beta production. Immunoblot analysis with a phosphospecific antibody showed that RIG-I serine 8 phosphorylation steady-state levels were decreased upon stimulation of cells with IFN-beta or virus infection. Substitution of serine 8 in the CARD RIG-I functional domain with phosphomimetic aspartate or glutamate results in decreased TRIM25 binding, RIG-I ubiquitination, MAVS binding, and downstream signaling. Finally, sequence comparison reveals that only primate species carry serine 8, whereas other animal species carry an asparagine, indicating that serine 8 phosphorylation may represent a primate-specific regulation of RIG-I activation. Collectively, these data suggest that the phosphorylation of RIG-I serine 8 operates as a negative switch of RIG-I activation by suppressing TRIM25 interaction, further underscoring the importance of RIG-I and TRIM25 connection in type I IFN signal transduction.
Nistal-Villán
Estanislao
E
Department of Microbiology, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1124, New York, NY 10029, USA.
Gack
Michaela U
MU
Martínez-Delgado
Gustavo
G
Maharaj
Natalya P
NP
Inn
Kyung-Soo
KS
Yang
Heyi
H
Wang
Rong
R
Aggarwal
Aneel K
AK
Jung
Jae U
JU
García-Sastre
Adolfo
A
D048868:Adaptor Proteins, Signal Transducing / Q000235:genetics / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites / Q000235:genetics; D015153:Blotting, Western; D002460:Cell Line; D045744:Cell Line, Tumor; D002522:Chlorocebus aethiops; D000071457:DEAD Box Protein 58; D053487:DEAD-box RNA Helicases / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D049452:Green Fluorescent Proteins / Q000235:genetics / Q000378:metabolism; D006801:Humans; D050838:Interferon Regulatory Factor-3 / Q000235:genetics / Q000378:metabolism; D016899:Interferon-beta / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology; D018613:Microscopy, Confocal; D008958:Models, Molecular; D009154:Mutation; D010766:Phosphorylation / Q000187:drug effects; D011401:Promoter Regions, Genetic / Q000235:genetics; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D011971:Receptors, Immunologic; D012694:Serine / Q000235:genetics / Q000378:metabolism*; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism; D015533:Transcriptional Activation; D014162:Transfection; D000070584:Tripartite Motif Proteins; D044767:Ubiquitin-Protein Ligases / Q000235:genetics / Q000378:metabolism; D014709:Vero Cells
D048868:Adaptor Proteins, Signal Transducing; D050838:Interferon Regulatory Factor-3; C505371:MAVS protein, human; D011971:Receptors, Immunologic; D014157:Transcription Factors; D000070584:Tripartite Motif Proteins; D049452:Green Fluorescent Proteins; D012694:Serine; D016899:Interferon-beta; C084523:TRIM25 protein, human; D044767:Ubiquitin-Protein Ligases; C452820:RIGI protein, human; D000071457:DEAD Box Protein 58; D053487:DEAD-box RNA Helicases
J Virol. 2000 Dec;74(24):11566-73
11090154
Sci STKE. 2002 Oct 15;2002(154):pl16
12381836
Nat Immunol. 2004 Jul;5(7):730-7
15208624
Immunity. 2006 Sep;25(3):373-81
16979569
Cell. 1995 Dec 29;83(7):1091-100
8548797
Cell. 2009 Aug 7;138(3):576-91
19631370
Cell. 2009 Jul 23;138(2):366-76
19632184
Annu Rev Biochem. 1998;67:227-64
9759489
J Virol. 2008 Jan;82(1):335-45
17942531
Nat Protoc. 2009;4(3):363-71
19247286
Nature. 2007 Apr 19;446(7138):916-920
17392790
Immunity. 2005 Jul;23(1):19-28
16039576
Mol Cell. 2005 Sep 16;19(6):727-40
16153868
Ann N Y Acad Sci. 2008 Nov;1143:1-20
19076341
J Exp Med. 2008 Jul 7;205(7):1601-10
18591409
Immunity. 2009 Jul 17;31(1):25-34
19576794
Proc Natl Acad Sci U S A. 2000 Apr 11;97(8):4309-14
10725408
Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12067-72
19574455
J Virol. 2007 Jan;81(2):514-24
17079289
Proc Natl Acad Sci U S A. 2007 Jan 9;104(2):582-7
17190814
Cell. 2000 Nov 10;103(4):667-78
11106736
J Virol. 2008 Feb;82(3):1474-83
18057259
J Virol. 2007 Jul;81(13):7011-21
17442719
Cell. 2005 Sep 9;122(5):669-82
16125763
J Biol Chem. 2009 Jan 9;284(2):807-17
19017631
J Virol. 2010 Apr;84(7):3220-9
20071582
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16743-8
18948594
Mol Cell. 2008 Feb 1;29(2):169-79
18243112
Mol Cell. 2007 Jun 8;26(5):703-16
17560375
Mol Cell. 2008 Feb 29;29(4):428-40
18242112
Nat Immunol. 2005 Oct;6(10):981-8
16127453
Science. 2006 Nov 10;314(5801):997-1001
17038589
Immunity. 2008 Aug 15;29(2):178-81
18701081
Cell. 2005 Sep 9;122(5):645-7
16143094
J Exp Med. 2002 Feb 18;195(4):F15-8
11854366
Nat Immunol. 2009 Oct;10(10):1065-72
19609254
PLoS One. 2009 Jun 01;4(6):e5760
19484123
J Biol Chem. 2008 Jan 4;283(1):76-86
17977820
Nature. 2007 Aug 16;448(7155):816-9
17653195
Nature. 2005 Oct 20;437(7062):1167-72
16177806
Mol Cell. 1998 Mar;1(4):507-18
9660935